Conference Overview
Inhaled drug delivery is achieved using four principle technologies, dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. Although there are many differences between these technologies there are many fundamental principles that are followed to achieve an effective delivered dose, as such there is much shared learning
across the technologies.
This meeting includes presentations on each of these delivery technologies with the intent to share knowledge and learning across the inhaled drug development business. The future European and UK regulatory processes following Brexit will be critical when developing product approval strategies, we shall be considering regulatory issues on this and other important hot topics.
There are a number of key areas that are currently evolving and the latest thinking and progress on these will be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.
Inhaled drug delivery is achieved using four principle technologies, dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. Although there are many differences between these technologies there are many fundamental principles that are followed to achieve an effective delivered dose, as such there is much shared learning
across the technologies.
This meeting includes presentations on each of these delivery technologies with the intent to share knowledge and learning across the inhaled drug development business. The future European and UK regulatory processes following Brexit will be critical when developing product approval strategies, we shall be considering regulatory issues on this and other important hot topics.
There are a number of key areas that are currently evolving and the latest thinking and progress on these will be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.
